APA (7th ed.) Citation

G, B. B., C, B., BJ, B., MP, T., AT, P., F, F., . . . AT, K. (2026). [177Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastases. European journal of nuclear medicine and molecular imaging, 53(2), 824. https://doi.org/10.1007/s00259-025-07447-0

Chicago Style (17th ed.) Citation

G, Belge Bilgin, et al. "[177Lu] Lu-PSMA-617 Treatment for Metastatic Castration-resistant Prostate Cancer (mCRPC) with Cerebral and Cerebellar Metastases." European Journal of Nuclear Medicine and Molecular Imaging 53, no. 2 (2026): 824. https://doi.org/10.1007/s00259-025-07447-0.

MLA (9th ed.) Citation

G, Belge Bilgin, et al. "[177Lu] Lu-PSMA-617 Treatment for Metastatic Castration-resistant Prostate Cancer (mCRPC) with Cerebral and Cerebellar Metastases." European Journal of Nuclear Medicine and Molecular Imaging, vol. 53, no. 2, 2026, p. 824, https://doi.org/10.1007/s00259-025-07447-0.